| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.0011 | 1 |